Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
Archive print banner
The FIBROID Registry

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to www.ahrq.gov for current information.

Table 20. Additional Outcome Measures

Variable

Level

0-6 Months

6-12 Months

Total N
(1,797)

%

Total N
(1,701)

%

Unwanted changes in sexual functioning

Strongly agree

35

1.95

61

3.59

Agree

129

7.17

151

8.88

Undecided

226

12.57

222

13.05

Disagree

498

27.70

451

26.51

Strongly disagree

847

47.11

756

44.44

Vaginal discharge

No

853

81.47

1226

82.45

Yes

182

17.38

241

16.21

Duration of discharge (days)

Mean (days)

90

11.37

106

8.44

STD

 

14.28

 

8.22

Median

 

6.50

 

6.00

25th percentile

 

3.00

 

3.00

75th percentile

 

14.00

 

14.00

Saw physician for treatment

No

123

67.58

146

60.58

Yes

58

31.87

87

36.10

Medication for treatment

Yes

30

51.72

44

50.57

Was treatment effective?

No

6

20.00

15

34.09

Yes

22

73.33

27

61.36

Return to Document

 

The information on this page is archived and provided for reference purposes only.

 

AHRQ Advancing Excellence in Health Care